Where a study on metformin and cardiovascular disease fell short – and what it can teach us
An investigation on metformin, diabetes, lipid biology, and cardiovascular disease offered little insight on any of these topics, but it illustrates common problems in scientific research
Is low-to-moderate alcohol consumption beneficial for longevity?
There is a common belief that low-to-moderate consumption of alcohol has unique health benefits. What does the evidence show?
Do GLP-1 receptor agonists improve cardiovascular health independently of weight loss?
A new trial has reported that the GLP-1 receptor agonist semaglutide reduces risk of cardiovascular events in patients with obesity – but that’s not the question we ought to be asking.
More than glycemic control: SGLT2 inhibitors may extend lung cancer survival
A retrospective study offers hope